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Abstract: Spinal cord neurostimulation is a minimally invasive treatment method for 
chronic neuropathic pain that is refractory to treatment, and is part of top technology in 
field. Relatively recent introduction of this method in the Neurosurgery Clinic "Prof. Dr. 
N. Oblu "of Iasi has aligned the clinic's therapeutic arsenal to world standards. This has 
made it possible to treat in Romania a category of patients who would be treated abroad 
until now. Our clinic has entered the "National Program for diagnostic and treatment 
using high performance equipment "- Subprogram of treatment of neuropathic pain by 
implant of a spinal cord neurostimulator and is currently the only one in Romania where 
this treatment can be done.  This represents a new step in the transformation process of 
the Clinical Hospital Emergency "Prof. Dr. N. Oblu" Iasi in a real Center of Excellence in 
the field Neurosurgery. The team dealing with the implant consists of 3 neurosurgeons, 
a neurologist, pa sychologist and an anesthetist, trained in a specialized foreign center. 
Key words: spinal cord stimulation, back pain, central nervous system stimulation, 
complex regional pain syndrome, failed back surgery syndrome 
 
History 
    Electrotherapy of pain by 
neurostimulation began shortly after in 1965 
R.Melzack and P. Wall proposed gate control 
theory (theoretical basis) spinal cord 
neurostimulation, wherefore they received the 
Nobel Prize [1]. According to this theory, 
nerves that carry painful peripheral stimuli, 
touch sensations and vibration end in the 
dorrsal horn (the gate) of the spinal cord. 
Thus, it has been hypothesized that this entry 
may be manipulated to "close the gate", thus 
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blocking the spread of the painful impulse. On 
this theory, in 1971, Shealy et al. [2] performed 
the first implant of the spinal cord 
neurostimulator in the treatment of chronic 
pain. Shimogi et al [3] published the analgesic 
effect of neurostimulation. Later spinal cord 
neurostimulation developed very rapidly over 
the last two decades by introducing 
implantable neuropeacemakers using guided 
surgical systems. [4]. Every year, over 50,000 
neurostimulation implants are performed 
worldwide. [5]. 
Chronic neuropathic pain 
Pain is “An unpleasant experience that we 
primarily associate with tissue damage or 
describe in terms of tissue damage.” 
(International Association for the Pain Study 
(IASP, 1986)). According to statistics, in 
Europe 1 out of 5 patients (70 millions of 
adults) suffer from chronic pain [6]. If in most 
patients the pain is the symptom of a disease, 
this is not always true. In 7 - 8% of the patients 
the pain persists even after removing the 
trigger factor. This pain ceases to be one 
symptom, becoming itself a disease. In recent 
years, medicine has begun to recognize that 
chronic pain is a self-esteem disease, after a 
long time it was considered a psychological 
and overlooked problem. This type of pain is 
refractory to common medication (non-
steroidal analgesics, anti-inflammatory drugs, 
opioids), physiotherapy and infiltration local. 
Therefore, it requires a totally different 
approach to traditional treatment strategies. 
The difficulty of treating neuropathic pain is 
also explained by the lack of knowledge the 
mechanisms that trigger it. Up to now, at least 
20 such pathophysiological mechanisms have 
been known. Neuropathic pain is caused by a 
decrease in the excitability threshold of a 
receptors, poor processing of nociceptive 
stimuli (neurons become over-excited, 
continuing to emit electrical impulses long 
after the trigger factor has been removed), 
disruption of the neuronal control mechanism 
(ineffective cells with inhibitor effect on it), 
etc. 
The pain process goes through 4 stages: 
transduction, transmission, perception, and 
modulation. Factors stimulants (ATP, GABA, 
glutamate, nitric oxide, prostaglandin and 
substance P mediators) irritate the free 
nervous terminations that respond to pain, 
and transformation into the electrical signal by 
transduction appears. This signal enters the 
spinal cord through the posterior horns and 
propagates ascending to the brainstem, and 
from there to the limbic system and thalamus. 
Here the signals of pain are processed and 
contextualized in the perception process. 
Through modulation, the brain can alter the 
transmission of subsequent nerve impulses by 
amplifying or reducing the release of 
neurotransmitters. 
Symptomatology of chronic neuropathic pain 
- Due to the long-term nervous disorders, 
the symptoms are more important in the distal 
extremities (soles, palms) than in thighs or 
arms. 
- no visible damage 
- dysaesthesia - an alteration of sensitivity 
leading to spontaneous unpleasant sensations 
such as those tingling, sting and burning; 
- allodynia - pain caused by stimuli that are 
normally painless. This stimulus can be touch 
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(for example, touching a feather) or heat 
(when the pain is caused by a temperature that 
would not normally be disturbing); 
- a paradoxical combination of loss of 
sensitivity and hyperalgesia of  painful area, 
the presence of paroxysms  
- autonomic hyperactivity - abnormal 
blood flow, hyperthermia and skin sweating 
accompany the painful sensation and 
contribute to its persistence (for example, in 
complex regional pain syndromes). 
Chronic neuropathic pain is refractory to 
treatment with analgesics or opioids, but it  
improves with antidepressants, antiepileptic 
and vasodilators, as well as application to the 
painful place of hot-cold compresses.  
Spinal cord neurostimulation 
a) Indications: 
- FBSS - Failed Back Surgery Syndrome 
(FBSS); 
- Regional Complex Pain Syndrome (CPRS) 
type I (also called sympathetic dystrophic 
reflex) and type II (also called causal); 
- Diabetic neuropathy; 
- Neuralgia postherpetica. 
- Amyloidosis neuropathy; 
- Neuropathy from Fabry disease; 
- Polyradiculoneurita Guillain-Barré; 
- Neuropathy from peripheral vascular 
disease; 
- Lyme disease (Borreliosis, 1000-sided 
illness); 
- Toxic (ethanolic) neuropathy; 
- Neuropathy from vitamin deficiencies in 
group B; 
- Ghost pain in vertebral-medullary trauma; 
- Pain in oncology pathology; and so on 
b) Contraindications: 
- The presence of other electrical devices in 
the body (cardiac pacemaker, cochlear 
implant), because the electrical impulses of 
the neurostimulator can interfere with the 
electrical impulses of these devices; 
- Serious heart disease (class III-IV 
N.Y.H.A., valvular stenosis, angina 
pectoris); 
- Blood clotting disorders - Patients with 
chronic anticoagulant therapy present an 
increased risk of developing peridural 
hematomas at the implant site and spinal 
cord compression, sometimes with motor 
deficits; 
- Psychiatric disorders, drug abuse and / or 
addiction; 
- Trophic or gangrene ulcers; 
- Local infections; 
- Immune system deficiencies; 
- Patient incapacity to use implanted device 
and inability to present at control visits; 
- Age under 18. 
Female candidates with fertile potential 
should have a urine pregnancy test and use 
contraceptive methods recommended by the 
investigator. 
 c) The neurostimulation system 
It includes several components: electrode, 
extension, impulse generator (trial and 
permanent), patient remote control, physician 
programmer. 
Stimulation electrode. There are several 
types of electrodes that differ in number of 
contacts, stimulation contact length, contact 
distance etc. We used electrodes with lengths 
between 50 and 75 cm and diameter of 1.5 mm, 
with 8 contacts and resistance up to 250Ω.  
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Figure 1 - Different types of stimulation electrodes 
 
 
Figure 2 - Stimulation electrode – schema 
 
The extension connects the stimulating 
electrode to the impulse generator. 
 
Figure 3 – Extension 
 
Figure 4 - External generator (trial) 
 
The pulse generator is a device designed to 
provide electrical impulses to the stimulating 
electrode. Includes a battery with at least 2.5 
Ah, which generates pulses with maximum 
voltage up to 10.5 volts, frequency between 50 
and 120 Hz and duration between 100 and 500 
msec. The generator stores the stimulus 
program set up by the physician only from the 
amplitude, frequency, duration of the impulse, 
and the order of the stimulation contacts on 
electrode. It also memorizes the start and stop 
times of the generator, as well as the changes 
of the amplitude performed by the patient via 
the remote control. 
 
 
Figure 5 - Compatible IRM Impulse Pump Generator 
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The life span of the power supply is 3 to 5 
years and can be replaced after consumption. 
New generators are IRM compatible, 
rechargeable and automatically adjusts their 
pulse voltage depending on the position of the 
body. 
Remote. It is used by the patient to transmit 
and receive wirelessly data to the spinal cord 
neurostimulator. Through this, the patient can 
optimize settings, can completely reset or shut 
down the spinal cord neurostimulator in case 
of fluctuations feeding or accidental exposure 
to a powerful electromagnetic field, adjusts the 
amplitude of the pulse based on the limits 
prescribed by the physician. Using the remote 
control the patient can check the status of the 
spinal cord neurostimulator battery located in 
the generator pulses, patient remote control 
battery and confirmation that the 
neurostimulator has received the information 
from the remote control. 
 
 
Figure 6 - Patient remote control 
 
N-Vision is a small portable computer 
specializing in the programming of generators 
pulses. The data transmission between N-
Vision and the generator is 2.4 GHz. Through 
the programmer, the physician sets up a 
stimulus program adapted to each patient by 
modifying the parameters of these impulses to 
the maximum therapeutic efficiency and order 
electrode stimulation contact. 
 
 
Figure 7 - The N'Vision programmer 
 
The mechanism of action of the spinal cord 
neurostimulator consists in blocking the 
transmission painful impulses in the upward 
spinal tracts to the thalamus and limbic 
system, where integration, analysis and 
awareness of suffering is taking place. The 
effect of neuromodular, which consists of 
suppressing the release of inhibitory chemical 
neuromodulators suppress the transmission of 
pain. This mechanism of functioning also 
derives from the fact that the pain is 
suppressed minutes, hours to even days after 
stopping the pacemaker. This could is due to 
the fact that the spinal cord neurostimulation 
increases the synthesis of the GABA 
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neurotransmitter, which has an effect of 
removing amino acid excitators. 
Until the introduction of spinal cord 
neurostimulation, the only way to resolve pain 
was surgery to discontinue the paths carrying 
the pain signals. But the key success was the 
finding of carrier tracts, often the intervention 
being a failure. 
Objectives 
This study presents the preliminary results 
of the stimulation of the posterior tracts of 
spinal cord via neurostimulatory implant in 
chronic neuropathic pain, performed in the 
Clinic of Neurosurgery Iasi. 
Selection of patients  
From 2015 until now in our clinic we have 
performed 36 implant procedures at 22 
patients: 14 women and 8 men between 40 and 
76 years of age with an average disease 
progression of 2.8 years and an average of 2 to 
3 neurosurgical interventions per patient. 20 
cases were with failed back surgery syndrome 
(FBSS) after repeated neurosurgical 
interventions for both herniated lumbar discs, 
as well as after decompression in foraminal 
and / or spinal stenosis, degenerative 
spondylolistezis, peridural and radicular 
fibrosis, 1 case with ghost pain after dorsal 
inferior vertebromedular trauma, 1 complex 
complex regional posttraumatic pain 
syndrome (CRPS) type I (sympathetic 
dystrophic reflex) and a case of persistent pain 
after repeated interventions for trigeminal 
neuralgia. The implant was done in 2 steps - 
test stimulation and permanent implant. 
 
 
Figure 8 - VAS scale 
 
Neurological consult. The vast majority of 
cases selected for the implant were patients 
with the failed back surgery syndrome, with 
outstanding pain, irradiated in the inferior 
limb neuropathy-like (spontaneous, non-
effortless, with paroxysmal exacerbations), 
with an intensity of over 7 in the analog-visual 
scale (VAS), measured 3 times a day within 3 
days. All the patients did medical treatment, 
physiotherapy and spinal infiltration up to 6 
months. There were followed the beginning, 
character, duration, intensity, territory and 
evolution of pain. The essential features of this 
type of pain was allodynia, hyperalgesia and 
hyperpathia. The neurological examination 
showed that these clinical signs coexisted 
frequently in our cases and were very difficult 
to differentiate. 
Psychological consultation has been done 
in all patients, primarily to exclude any 
psychological problem that could affect the 
outcome. The most common effects secondary 
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to the neuropathic pain were depression, 
anxiety, somatization, sleep, family and / or 
marital problems. Cases with obvious signs of 
somatization of pain and those with a history 
of suicidal ideas were sent to psychiatric 
examination and excluded from the batch. It 
was important to establish realistic 
expectations by the patient: the efficiency of 
stimulation between 40% and 60% of the cases, 
and the efficiency criterion - the reduction by 
at least 50% of the intensity pain and decreased 
analgesic drug intake. It is also important to 
grant support and encourage pain patients. 
The Roland-Morris Questionnaire (2004) 
The patient draws on the dermatomus 
distribution charts in different colors the 
location of the pain, a numbness or burning 
feeling. 
 
 
Figure 9 - These charts are very useful 
intraoperatively for covering painful areas 
 
 
Patients with inflammatory and purulent 
skin rashes, as well as those with local irritation 
secondary to various physiotherapeutic 
procedures located even at a distance from the 
placement of the electrode impose the delay of 
the surgery until these are resolved. 
Preparing the patient for the implant. The 
selected cases for the implant benefited from 
spinal MRI exam, primarily to exclude injuries 
that would require reintervention, the level of 
the conus medullaris. 
Sometimes we use CT to evaluate the 
anatomical area of the implant (highlighting 
the possible spinal abnormalities, narrow 
spaces, etc.) that could pose technical 
problems in performing the implant safely. 
 
 
Figure 10 - CT reconstruction for the anatomical 
evaluation of the implant area 
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Provisional implant technique 
The patient's position on the operative table 
is ventral decubitus. Anesthesia is intravenous, 
the patient being conscious throughout the 
intervention. Radiological survey a projection 
of laryngeal apophyses L3-L4. 
 
 
Figure 10 - Set up the implant room 
 
After local anesthesia with Xilina 1%, 
vertical cutaneous incision is performed on a 
length of 3-4 cm, on the median line. Touhy 
needle (hypodermic needle, slightly curved at 
the end, also used in implantation of epidural 
catheters) is inserted at 45° from the spinal 
axis, obliquely to the median line, on left or 
right to spinous apophyses (depending on 
lateral pain) until cessation resistance after 
passing the yellow ligament. Typically the 
channel is entered through the L2-L3 lamina 
below the level of the conus medullaris (to 
avoid direct lesion). After extraction the stylet 
through the needle lumen, one inserts the 
electrode into the posterior epidural space. 
The electrode must cross at least 4 vertebrae 
from the place of introduction to the 
stimulation area. 
The electrode is driven under C-ARM control 
to the desired location, depending on the location 
of the pain area in the lower limbs (usually up to 
the back of the D9-D10 vertebral body). 
 
Figure 11 - Insertion of the electrode to the posterior 
epidural space 
 
 
Figure 12 - Radiological control of correct 
positioning of the electrode 
 
The electrode is connected via extension to 
N'vision programmer and the unscrubbed 
physician produces the first electrostimulation 
of the posterior cords. The patient indicates 
the area the painful condition is covered by 
paresthesia ("tingling") and decreased 
intensity of pain. 
 
 
Figure 13 - Intraoperative medullary stimulation 
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After radiological confirmation of correct 
electrode position and good stimulation 
intraoperatively, the extension is 
transcutaneously exteriorized on the lateral 
side of the trunk and sutured to the tegument. 
The wounds are sutured, and the distal end of 
the extension connects to the temporary 
impulse generator. The whole system is 
attached to the skin with adherent drape. 
 
 
Figure 14 - Externalization of the extension and 
connection to the external generator 
 
Suture suppression is done after 6-7 days 
postoperatively. For 2 to 3 weeks the patient is 
in the neurostimulation test period. The 
patient is called for visits repeatedly to adjust 
the electrical parameters of impulse by 
intensity, voltage, amplitude and its duration. 
Depending on the position of the body (bent, 
sitting or orthostatism) the electrode can move 
farther or closer to the back of the spinal cord 
requiring manual adjustment to the patient's 
power of impulse for an effective stimulation 
of the spinal cord. The patient is taught to 
control his own pain by using his personal 
remote depending on his daily activities.  
Security measures. Patients have forbidden 
activities involving sudden shocks, twists or 
excessive trunk flexion, as it may cause 
disconnection or breakage of the components 
system. This can lead to intermittent 
stimulation or even loss of stimulation. Special 
warnings and increased attention are required 
when a defibrillation is required, 
electrocauterizations, MRI exams, 
radiofrequency ablation and endoscopy for 
therapeutical purpose, as powerful sources of 
electromagnetic interference can cause 
overheating the components of the 
neurostimulation system with tissue damage. 
There can occur instantaneous increases in 
stimulation intensity or intermittent 
stimulation, and the patients may feel 
vibrations or shocks, return to initial 
symptoms or even need reprogramming the 
neurostimulator. Although it can create 
discomfort, all of this does not lead to device 
malfunction or serious injury to the patient. 
The permanent implant technique 
If during the test stimulation the pain 
intensity decreased by at least 4 to 5 points on 
pain scale or more than half of its intensity 
with gradual decrease in medication doses, is 
decided to perform the permanent implant. It 
involves the replacement the external 
provisional generator with a sterile one. The 
place where the generator will be implanted 
must either be easily accessible to the patient 
for easy synchronization with personal remote 
control. The exact location of the implant is 
established preoperatively in agreement with 
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the patient to avoid it overlaps with the level at 
which he usually wears his belts / trousers. 
Internalisation of the sterile generator is done 
subcutaneously, usually on the anterior face of 
the abdomen, paraumbilical left. 
The permanent implant is done under 
general anesthesia via oro-tracheal intubation. 
The position of the patient on the operating 
table is in lateral decubitus, with the painful 
side up. Preparation the operator field is 
similar to the provisional implantation 
technique with the reference that apart from 
the lumbar region it will disinfect the anterior 
face of the abdomen, where the sterile impulse 
generator is to be implanted. 
 
 
Figure 15 - Prepare the operator field for the 
permanent implant 
 
 
Figure 16 - Subcutaneous tunneling of the extension 
 
The wound is reopened where the 
connection between the electrode and the 
extension was made. One disconnects and 
suppress the extension with the non-sterile 
external generator. Another extension is 
added, sterile, that is connected to the 
electrode implanted in the previous 
intervention. Extension cable is tunned 
subcutaneously to the anterior face of the 
abdomen, where it connects to the sterile 
generator and itself inserted into the 
subcutaneous paraumbilical pocket. 
The generator is fixed with non-resorbable 
sutures to the abdominal muscle. The wound 
will be sutured with vicryl 3.0 (skin Ethilon 3.0). 
 
 
Figure 17 - Connect the extension to the generator 
 
 
Figure 18 - Internalizing the generator in the 
paraumbilical pocket 
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Surgical Electrodes in Chronic Pain 
Management. Another type of electrodes we 
used are the Specify ™ surgical electrode. It has 
the shape of a 16-palletized blade 
programmable independently and assigned in 
3 rows 5-6-5. 
 
 
Figure 19 - Specify ™ Surgical Electrodes 
 
This type of electrode offers several options 
and configurations for customized therapy 
individually to each patient. First, it is more 
effective in cases of associated irradiated pain 
with vertebral syndrome. The Specify ™ 
electrode is implanted after a good stimulation 
with percutaneous electrode during the test 
period. The surgical implant is made with 
general anesthesia after bilateral traction of 
muscle masses and lower partial lamina 
resection at level D11. 
 
Figure 20 - Radiological control - Specify ™ electrode 
positioned at D9 
 
Insert the electrode into the D9 - D10 
retrodural space. Otherwise - connections to 
the generator are performed via the extension 
– similar to the tehnique of implant of the 
percutaneous electrode. The surgical electrode 
has the advantage of a larger coating and the 
minimal risk of slipping from the 
percutaneous space, but has the greater risk of 
septic complications. From the point of view 
of battery consumption, the surgical electrode 
has one much higher than the percutaneous 
yield, being the electromagnetic field at the 
surgical one is oriented in one direction, while 
the percutaneous electrode is directed at 360°. 
Intraoperative incidents: Of the 30 
procedures performed in 2 cases we found the 
presence of CSF in the penetration of the 
yellow ligament with the Touhy needle. Both 
cases required 2 - 3 days of bed rest, the period 
of postpunctional cephalalgia. 2 cases with the 
migration of the electrode required 
repositioning, 3 cases of remediation with the 
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replacement of the damaged elements of the 
circuit and a case of infection with the 
staphylococcus aureus required system 
suppression. 
Results 
The effectiveness of spinal cord 
neurostimulation was based on average 
comparison results of pain intensity before 
and after implant, performed 3 times a day. 
We have noted a reduction in pain intensity on 
average by 4.7 p. on the VAS scale and 
improvement in functional capacity and 
quality of life in 67% of cases. The best results 
were obtained in patients aged 20-60 years 
with a disease progression up to 2 years, with a 
maximum of 2 to 3 neurosurgical 
interventions on the spine, prevalence of 
radicular syndrome on the vertebral syndrome 
and with minimal psychological changes. 
Perspectives: We intend to extend the 
procedure's indications to neuropathies of 
various etiologies, stimulation of sacral nerve 
in sphincter disorders, gastric and colon 
stimulation for gastrointestinal disorders, 
vagal nerve stimulation in epilepsy, carotid 
stimulation for hypertension, etc 
Conclusions 
- The spinal cord neurostimulator is a 
medical standard that benefits tens of 
thousands of people worldwide every year; 
- Neurostimulation reduces the need for 
drugs and their side effects. 
- Neuroaugmentation is a minimally 
invasive, nonablative and reversible 
procedure a relatively low incidence of 
complications and a wide range of benefits. 
- The level of spinal cord stimulation can be 
adjusted and programmed hourly, day and 
night; 
- It does not produce irreversible changes in 
the spinal cord or nerves, and the system 
implanted can be disabled or removed 
without consequences; 
- Does not cause habit or addiction; 
- Absence of complications or sequelae 
characteristic of destructive methods 
within surgical treatment; 
- Neurostimulation radically improves the 
quality of life and enables social and 
economics reintegration of patients. 
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